Average per capita net availability of foodgrain declined in every five-year period of the 'reforms' without exception. In the 20 years preceding the reforms — 1972-1991 — it rose every five-year period without exception. The country's total foodgrain production is expected to touch a record 250 million tons this year (2011-12). Union Agriculture Minister Sharad Pawar PTI, February 17, 2012 Record foodgrain output of 235.88 million tons in 2010-11. Sharad Pawar, PTI, April 6, 2011 India's foodgrain...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...

At a time when economic wisdom is seen as lying in allowing unrestrained play of economic power and cutting social sector spending, here is a report emphasising the economic sense in addressing hunger, especially child malnutrition. It also brings out the positive impact of employment guarantee scheme, which has been a thrust area of the UPA government but has seen a cut in allocation in Budget proposals for 2012-13. The report...

India will be one of the youngest nations by 2020 and this changing demographic condition, while providing great opportunities, could pose some challenges too, the Economic Survey 2011-12 has said. India is passing through a phase of unprecedented demographic changes, wherein the proportion of the working age population (15-59 years) is likely to rise from around 58 per cent in 2001 to over 64 per cent by 2021, according to the...

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...